Related Experiment Video
Updated: Jul 14, 2026

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
Published on: March 24, 2017
Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts
Yoshihide Asano1, Hironobu Ihn, Kenichi Yamane
1Department of Dermatology, Faculty of Medicine, University of Tokyo, Tokyo, Japan.
Abstract:
The principal effect of TGF-beta1 on mesenchymal cells is its stimulation of ECM synthesis. Previous reports indicated the significance of the autocrine TGF-beta loop in the pathogenesis of scleroderma. In this study, we focused on Smad7 and Smurfs, principal molecules in the negative regulation of TGF-beta signaling, to further understand the autocrine TGF-beta loop in scleroderma. Scleroderma fibroblasts exhibited increased Smad7 levels compared with normal fibroblasts in vivo and in vitro. Smad7 constitutively formed a complex with the TGF-beta receptors, and the inhibitory effect of Smad7 on the promoter activity of human alpha2(I) collagen and 3TP-lux was completely impaired in scleroderma fibroblasts. Furthermore, the protein stability of TGF-beta receptor type I was significantly increased in scleroderma fibroblasts compared with normal fibroblasts. There was no significant difference in Smurf1 and Smurf2 levels between normal and scleroderma fibroblasts, and the transiently overexpressed Smurf1 and/or Smurf2 did not affect TGF-beta receptor type I protein levels in scleroderma fibroblasts. These results indicate that the impaired Smad7-Smurf-mediated inhibitory effect on TGF-beta signaling might contribute to maintaining the autocrine TGF-beta loop in scleroderma fibroblasts. To our knowledge, this is the first report of a disturbed negative regulation of TGF-beta signaling in fibrotic disorders.
Insights
Scleroderma fibroblasts show impaired Smad7 regulation of TGF-beta signaling, contributing to the disease
Area of Science:
- Cell Biology
- Molecular Biology
- Fibrosis Research
Background:
- Transforming Growth Factor-beta1 (TGF-beta1) stimulates extracellular matrix (ECM) synthesis in mesenchymal cells.
- Autocrine TGF-beta loops are implicated in the pathogenesis of scleroderma, a fibrotic disorder.
Purpose of the Study:
- To investigate the role of Smad7 and Smurfs in the negative regulation of TGF-beta signaling within the context of scleroderma.
- To elucidate the mechanisms maintaining the autocrine TGF-beta loop in scleroderma fibroblasts.
Main Methods:
- Comparison of Smad7 and Smurf levels in scleroderma and normal fibroblasts (in vivo and in vitro).
- Analysis of Smad7 complex formation with TGF-beta receptors.
- Assessment of Smad7's inhibitory effect on collagen and reporter gene promoter activity.
- Evaluation of TGF-beta receptor type I protein stability.
Main Results:
- Scleroderma fibroblasts display elevated Smad7 levels and impaired Smad7-mediated inhibition of TGF-beta signaling.
- TGF-beta receptor type I protein stability is increased in scleroderma fibroblasts.
- Smurf1 and Smurf2 levels are comparable between normal and scleroderma fibroblasts, and do not influence TGF-beta receptor type I stability.
Conclusions:
- Disturbed negative regulation of TGF-beta signaling, specifically impaired Smad7 function, likely contributes to the persistent autocrine TGF-beta loop in scleroderma.
- This study provides novel insights into the molecular mechanisms underlying fibrosis in scleroderma.
More Related Videos
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
Related Concept Videos
TGF - β Signaling Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...